secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2024-07-23T23:59:59+00:00
Accession:  0001022079-24-000153
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quest Diagnostics beats Q2 estimates, raises full-year guidance; announces four acquisitions
--------------------------------------------------------------------------------

- Q2 revenues $2.397B (+2.5% YoY); reported EPS $2.03 (-1% YoY), adjusted EPS $2.35 (+2.2% YoY)
- Full-year 2024 revenue guidance raised to $9.50-9.58B; adjusted EPS raised to $8.80-9.00
- Announces four acquisitions: LifeLabs (pending), Allina Health, OhioHealth outreach labs, PathAI Diagnostics (completed)
- Base business revenue growth ~4%; driven by new customers, advanced diagnostics, healthcare utilization
- Cash from ops guided ~$1.3B; capex ~$420M; both unchanged from prior guidance

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000102207924000153/0001022079-24-000153-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000102207924000153/dgx-20240723.htm
  HTML page:      https://secwatch.observer/filing/0001022079-24-000153

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer